The Ensign Group, Inc. vs Abbvie Inc.
ENSG vs ABBV — side-by-side comparison from reported financials. ENSG leads 6, ABBV leads 6 of 12 comparable metrics.
The Ensign Group, Inc.
ENSG · Healthcare
$171.80+0.18%Solid
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | ENSG | ABBV |
|---|---|---|
| Price | $171.80 | $276.43 |
| Market cap | $10.0B | $488B |
| Revenue (TTM) | $5.49B | $64.4B |
| Revenue growth | +18.7% | +1.8% |
| Net margin | 6.9% | 9.8% |
| Free cash flow | $608M | $18.2B |
| Net cash (debt) | ($1.63B) | ($56.2B) |
| 1-year price return | -2.3% | +19.8% |
| P/E | 26.4 | 77.4 |
| P/E vs own history (cheap-side %) | 48% | 23% |
| Dividend yield | 0.15% | 2.45% |
| Return on equity | 17% | 96% |
| Altman Z-score | 3.00 | 2.33 |
| CV checks passed | 11 of 11 | 9 of 11 |
| Employees | 46,000 | 57,000 |
Full résumé-style profiles: ENSG CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.